Prevnar 20
Merck & Co raises pressure on Pfizer in pneumococcal vaccine tussle
Phil Taylor
Merck & Co, Pfizer, pneumococcal disease, Prevnar 13, Prevnar 20, vaccine, Vaxneuvance
0 Comment
FDA okays Merck’s would-be Prevnar rival Vaxneuvance
Phil Taylor
fda, Merck & Co, Pfizer, pneumococcal disease, Prevnar 13, Prevnar 20, V114, Vaxneuvance
0 Comment
Shot in the arm for Affinivax as it challenges Pfizer’s Prevnar
Phil Taylor
Affinivax, Astellas, Merck & Co, Pfizer, Prevnar 13, Prevnar 20, V114, vaccine
0 Comment
News/ News/ Sales and Marketing
FDA clears Pfizer’s Prevnar 20 for adults, as Merck rival nears decision
Phil Taylor
fda, Merck & Co, Pfizer, pneumococcal disease, Prevnar 13, Prevnar 20, V114
0 Comment